Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds and Insiders Love, Inc. (NASDAQ:AMZN)?

Is, Inc. (NASDAQ:AMZN) worth your attention right now? The best stock pickers are becoming less hopeful. The number of bullish hedge fund positions went down by 4 recently.

In today’s marketplace, there are dozens of indicators shareholders can use to track publicly traded companies. A pair of the best are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best hedge fund managers can trounce the S&P 500 by a very impressive amount (see just how much)., Inc. (NASDAQ:AMZN)

Just as key, optimistic insider trading sentiment is another way to break down the investments you’re interested in. As the old adage goes: there are many incentives for an executive to drop shares of his or her company, but only one, very simple reason why they would initiate a purchase. Several empirical studies have demonstrated the valuable potential of this tactic if shareholders understand where to look (learn more here).

With these “truths” under our belt, it’s important to take a glance at the latest action surrounding, Inc. (NASDAQ:AMZN).

How have hedgies been trading, Inc. (NASDAQ:AMZN)?

Heading into 2013, a total of 58 of the hedge funds we track were long in this stock, a change of -6% from one quarter earlier. With the smart money’s capital changing hands, there exists a few noteworthy hedge fund managers who were upping their holdings significantly.

When looking at the hedgies we track, Ken Fisher’s Fisher Asset Management had the most valuable position in, Inc. (NASDAQ:AMZN), worth close to $613 million, accounting for 1.7% of its total 13F portfolio. Sitting at the No. 2 spot is Lansdowne Partners, managed by Paul Ruddockáand Steve Heinz, which held a $483 million position; 0.2% of its 13F portfolio is allocated to the stock. Remaining peers that are bullish include Tiger Global Management LLC, John Griffin’s Blue Ridge Capital and Ken Griffin’s Citadel Investment Group.

Since, Inc. (NASDAQ:AMZN) has faced declining sentiment from hedge fund managers, logic holds that there were a few funds that decided to sell off their positions entirely in Q4. It’s worth mentioning that James Crichton and Adam Weiss’s Scout Capital Management sold off the largest position of the “upper crust” of funds we key on, totaling close to $89 million in stock., and George Soros of Soros Fund Management was right behind this move, as the fund said goodbye to about $66 million worth. These transactions are interesting, as total hedge fund interest fell by 4 funds in Q4.

How are insiders trading, Inc. (NASDAQ:AMZN)?

Insider purchases made by high-level executives is most useful when the primary stock in question has experienced transactions within the past half-year. Over the latest 180-day time period,, Inc. (NASDAQ:AMZN) has seen zero unique insiders purchasing, and 13 insider sales (see the details of insider trades here).

With the results exhibited by our studies, retail investors must always monitor hedge fund and insider trading sentiment, and, Inc. (NASDAQ:AMZN) applies perfectly to this mantra.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!